2-((((1r,4r)-4-hydroxycyclohexyl)thio)methyl)-8-methylquinazolin-4(3H)-one

ID: ALA5180051

PubChem CID: 138696699

Max Phase: Preclinical

Molecular Formula: C16H20N2O2S

Molecular Weight: 304.42

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc2c(=O)[nH]c(CS[C@H]3CC[C@H](O)CC3)nc12

Standard InChI:  InChI=1S/C16H20N2O2S/c1-10-3-2-4-13-15(10)17-14(18-16(13)20)9-21-12-7-5-11(19)6-8-12/h2-4,11-12,19H,5-9H2,1H3,(H,17,18,20)/t11-,12-

Standard InChI Key:  OSFGFBLRIXHPSO-HAQNSBGRSA-N

Molfile:  

 
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -3.2144    1.2374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4998    1.6496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7880    1.2378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7880    0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4980    0.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2144    0.4089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0733    1.6504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3585    1.2377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3585    0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0733    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0733    2.4754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3559    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3559   -0.8251    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0705   -1.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4980   -0.8243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7852   -0.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4998   -1.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4998   -2.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7852   -2.4754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0705   -2.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2144   -2.4754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  2  0
  4 10  1  0
  7 11  2  0
  9 12  1  0
 12 13  1  0
 14 13  1  1
  5 15  1  0
 16 14  1  0
 17 16  1  0
 18 17  1  0
 19 18  1  0
 20 19  1  0
 14 20  1  0
 18 21  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5180051

    ---

Associated Targets(Human)

PARP14 Tchem Poly [ADP-ribose] polymerase 14 (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 304.42Molecular Weight (Monoisotopic): 304.1245AlogP: 2.77#Rotatable Bonds: 3
Polar Surface Area: 65.98Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.75CX Basic pKa: 5.36CX LogP: 2.11CX LogD: 2.13
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.91Np Likeness Score: -0.90

References

1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O..  (2022)  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.,  65  (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281]

Source